Edition:
United States

Biotron Ltd (BIT.AX)

BIT.AX on Australia Stock Exchange

0.02AUD
18 Aug 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.02
Open
$0.02
Day's High
$0.02
Day's Low
$0.02
Volume
80,000
Avg. Vol
384,987
52-wk High
$0.07
52-wk Low
$0.02

Latest Key Developments (Source: Significant Developments)

Biotron updates on Bit225 Phase 2 HIV-1 clinical trial
Wednesday, 14 Jun 2017 09:19pm EDT 

June 15 (Reuters) - Biotron Ltd :Asx alert-bit225 phase 2 hiv-1 clinical trial update-bit.ax.Trial headline results anticipated Q3 this year.Independent data and safety monitoring committee unanimously voted to proceed with second, and larger, cohort at a higher dose.  Full Article

Biotron announces rights issue
Wednesday, 24 May 2017 07:51pm EDT 

May 25 (Reuters) - Biotron Ltd :Renounceable rights offered at 2 cents per share to raise up to $1.56 million.Net proceeds will be used to complete complementary non-clinical assays on samples from current phase 2 hiv-1 clinical trial.  Full Article

BRIEF-Biotron updates on Bit225 Phase 2 HIV-1 clinical trial

* Asx alert-bit225 phase 2 hiv-1 clinical trial update-bit.ax

No consensus analysis data available.